Month: February 2017

DYRK1A: Saint Malo’s flagship gene

For 15 years now, the Foundation has considered the gene Dyrk1a to be one of the main therapeutic solutions to curing Down Syndrome.

CiBleS21: New encouraging results

The Jérôme Lejeune Foundation is testing new inhibiting molecules to improve the cognitive functions in people living with Down Syndrome.

Yes, we are dissuasive !

Not in popular China, under Mao, but in France in 2017, to give out information likely to dissuade a woman from abortion is on the verge of becoming a crime punishable by a fine and time of prison.

The development of an international centre of excellence

Grégoire François-Dainville, the general director of the Jérôme Lejeune institute, has provided us with news concerning this unique centre that

Ségolène jumps at 4000 metres “wasn’t even scared”!

Ségolène rushed off for her first free-fall version of flying over her city, between Mouvaux and Bondues. The exploit is

Dear Future Mom

See more videos

Our newsletter

Institut medical office